文献速递眼底病与葡萄膜炎神经眼科

颈动脉内膜剥脱术与颈动脉支架植入术后视网膜动脉阻塞发生率比较

Incidence of Retinal Artery Occlusion After Carotid Endarterectomy Versus Carotid Artery Stenting.
PubMed 文献 · Retina · 2026-10-06

本研究为回顾性多中心队列研究,基于TriNetX数据库比较颈动脉内膜剥脱术(CEA)与颈动脉支架植入术(CAS)后视网膜动脉阻塞(RAO)及神经眼科结局的风险。经倾向评分匹配后每组17,851例,CAS组1年RAO、CRAO、BRAO及法定盲风险均显著高于CEA组,卒中与死亡率亦更高,但绝对事件率较低。结论提示CAS术后需加强眼科监测。

要点

  • CAS组1年RAO风险显著高于CEA组(0.421% vs 0.257%,OR 1.64)。
  • CAS组CRAO、BRAO及法定盲风险均显著高于CEA组。
  • 多数事件发生于术后72小时内,CAS组卒中和死亡率亦更高。

核心结论

  • 在倾向匹配的回顾性分析中,CAS与CEA相比与更高的视网膜及神经缺血并发症风险相关,但绝对事件率较低。

研究设计与样本

  • 回顾性多中心队列研究,使用TriNetX研究网络(2004年1月1日至2026年3月15日)数据。
  • 纳入接受CEA或CAS且随访≥6个月、无既往研究结局诊断的成人,经倾向评分匹配后每组17,851例。

主要发现

  • 1年时CAS组RAO发生率为0.421%,CEA组为0.257%(OR 1.64;95%CI 1.12-2.41)。
  • CAS组CRAO风险OR 2.30(95%CI 1.10-4.84),BRAO风险OR 3.21(95%CI 1.58-6.52),法定盲风险OR 1.59(95%CI 1.26-2.92)。
  • CAS组卒中发生率为6.20%,CEA组为4.43%(OR 1.42;95%CI 1.25-1.62);死亡率分别为6.41%和3.87%(OR 1.70;95%CI 1.54-1.88)。
  • 大多数事件发生于术后72小时内。

临床怎么用

  • CAS术后应考虑加强眼科 vigilance,并促进眼科与血管外科的跨学科协作。
  • 对选定高危患者,术后针对性眼科评估可能是合理的,有待前瞻性研究确认。

局限性

  • 回顾性观察性设计,结果需前瞻性 confirmation。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Retinal artery occlusion (RAO) is a rare but vision-threatening complication of carotid revascularization, yet its comparative incidence after carotid endarterectomy (CEA) versus carotid artery stenting (CAS) is poorly characterized. We compared the risk of RAO and associated neurologic outcomes after CEA and CAS. METHODS: Retrospective multicenter cohort study using the TriNetX Research Network (January 1, 2004-March 15, 2026). Adults undergoing CEA or CAS with ≥6 months of follow-up and no prior diagnosis of any studied outcome condition (retinal artery or vein occlusion, glaucoma, legal blindness, or stroke were included. Propensity score matching on demographics, comorbidities, ophthalmic conditions, medications, and laboratory biomarkers (nearest-neighbor greedy algorithm; caliper 0.25 SD) yielded 17,851 patients per cohort. The primary outcome was the incidence of RAO at 90 days and 1 year after the index procedure. Secondary outcomes included central RAO (CRAO), branch RAO (BRAO), retinal vein occlusion, glaucoma, legal blindness, stroke (stratified by National Institutes of Health Stroke Scale [NIHSS] score), and mortality at the same intervals. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated. RESULTS: At 1 year, CAS was associated with higher risks of RAO (0.421% vs 0.257%; OR 1.64; 95% CI, 1.12-2.41), CRAO (OR 2.30; 1.10-4.84), BRAO (OR 3.21; 1.58-6.52), and legal blindness (OR 1.59; 1.26-2.92). CAS also conferred higher odds of stroke (6.20% vs 4.43%; OR 1.42; 1.25-1.62) and mortality (6.41% vs 3.87%; OR 1.70; 1.54-1.88). Most events occurred within 72 hours post-procedure. CONCLUSION: In this retrospective propensity-matched analysis, CAS was associated with greater risk of retinal and neurologic ischemic complications than CEA, although absolute event rates were low. These observational findings support consideration of heightened postoperative ophthalmic vigilance and interdisciplinary collaboration between ophthalmology and vascular surgery after CAS and suggest that targeted post-procedural ophthalmic evaluation may be reasonable in selected high-risk patients, pending prospective confirmation.

来源:Retina,查看原文。版权归原作者所有。

引用

  1. Zaidi Z, Alshaikhsalama A, Winward B, et al. Incidence of Retinal Artery Occlusion After Carotid Endarterectomy Versus Carotid Artery Stenting. Retina. 2026. PMID: 42854197. doi:10.1097/IAE.0000000000005029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。